千红制药

002550 SZSE 证监会行业分类 C27医药制造业

Key Metrics

Market Cap

9.3B ($1.3B)

P/E Ratio

N/A

P/B Ratio

N/A

Revenue

1.5B

Net Income

333.0M

Gross Margin

N/A

Op. Margin

26.0%

Net Margin

21.8%

ROE

13.2%

ROA

11.8%

D/E

0.12

Dividend Yield

N/A

EPS

0.28

Current Ratio

7.60

Price History

Company Info

Industry	C27医药制造业
Market Segment	SME
Currency	CNY
Fiscal Year	2024

Business Overview

Changzhou Qianhong Biopharma CO.,LTD manufactures and distributes polysaccharide and protease drugs in China. The company offers heparin sodium, heparin calcium, enoxaparin sodium, dalteparin sodium, nadroparin calcium, pancreatin, heparinoid API, kallidinogenase, and asparaginase. It also provides low molecular weight heparin, compound digestive enzyme preparations, and health products. In addition, the company exports its products. The company was founded in 1971 and is headquartered in Changzhou, China.

Full Financials Advanced Charts Filings

Peers

工商银行

601398

2.7T

P/E: 7.6

建设银行

601939

2.5T

P/E: 7.2

农业银行

601288

2.4T

P/E: 8.7

中国海油

600938

2.0T

P/E: 16.2

宁德时代

300750

1.9T

P/E: 25.6

贵州茅台

600519

1.8T

P/E: 20.1

中国银行

601988

1.8T

P/E: 7.3

中国人寿

601628

1.2T

P/E: 6.9

Financial Statements

Loading financials...

Open Advanced Charts

Full charting with technical indicators, candlestick, and more.

About 千红制药

Ticker	002550
Exchange	SZSE
Sector	证监会行业分类
Industry	C27医药制造业